New Aspects of Antihypertensive Treatment

[1]  S. Haffner,et al.  Insulin sensitivity and hypertension. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[2]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[3]  P. Weidmann,et al.  Insulin, insulin sensitivity and hypertension. , 1990, Journal of hypertension.

[4]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[5]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[6]  C. Berne,et al.  Insulin resistance is a characteristic feature of primary hypertension independent of obesity. , 1990, Metabolism: clinical and experimental.

[7]  M. Moser.  Relative efficacy of, and some adverse reactions to, different antihypertensive regimens. , 1989, The American journal of cardiology.

[8]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[9]  H. Parving,et al.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. , 1988, BMJ.

[10]  W. Knowler,et al.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[11]  W. Miall,et al.  Mild hypertension is there pressure to treat an account of the mrc medical research council trial , 1987 .

[12]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[13]  G. Assmann,et al.  The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. , 1987, The American journal of cardiology.

[14]  J. Cutler,et al.  The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. , 1986, Progress in cardiovascular diseases.

[15]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[16]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[17]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[18]  H. Thurston,et al.  Hypertension with renal impairment: influence of intensive therapy. , 1974, The Quarterly journal of medicine.

[19]  W. Kannel,et al.  The relation of adiposity to blood pressure and development of hypertension. The Framingham study. , 1967, Annals of internal medicine.

[20]  T. Giles.  Antihypertensive therapy and cardiovascular risk. Are all antihypertensives equal? , 1992, Hypertension.

[21]  H. Jungbluth,et al.  Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  G. Mancia,et al.  Treatment of Hypertension and Ischemic Heart Disease , 1989, Journal of cardiovascular pharmacology.

[23]  J. Fuller.  Hypertension as a Risk Factor in Diabetes , 1988 .

[24]  G. Mancia.  Opening remarks: The need to manage risk factors of coronary heart disease , 1988 .

[25]  L. Wilhelmsen.  Coronary heart disease: epidemiology of smoking and intervention studies of smoking. , 1988, American heart journal.